CEP-1347

N/A

Report date: 2025/07/22 17:53:42

NME

Base Information

Drug NameCEP-1347

Drug Alias NameKT-7515CEP-1347

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMitogen-activated protein kinase kinase kinase 11 inhibitors

TargetsMitogen-activated protein kinase kinase kinase 11

Therapy Area/IndicationsParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesPuerto Rico

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKyowa Hakko

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCephalon

Active IndicationsN/A

Inactive IndicationsParkinson Disease

ATC CodeN/A